中文产业新闻精选评分80Chinese source
GSK 贝普若韦生在日本获批，为全球首批功能性治愈慢性乙肝 ASO 药物
全球首批！First-in-class 乙肝新药获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
全球首批！First-in-class 乙肝新药获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.